August 27, 2025

Clinical Trials and Research for Mantle Cell Lymphoma

Dana-Farber Cancer Institute is at the forefront of research in mantle cell lymphoma. We seek to advance more effective treatment options and reduce treatment side effects for patients with mantle cell lymphoma.

Dana-Farber

August 22, 2025

Evidence of Potential Cure With Single CAR T-Cell Infusion for Some Patients With Multiple Myeloma

In long-term results from the CARTITUDE-1 trial, investigators had found that the autologous cellular immunotherapy ciltacabtagene autoleucel was potentially curative for one-third of patients with he...

The ASCO Post

August 22, 2025

John C. Byrd, MD, FASCO, Named UPMC Hillman Cancer Center Director

An internationally lauded researcher and clinical specialist in hematologic malignancies has been appointed Director of UPMC Hillman Cancer Center, effective November 2025.

The ASCO Post

August 22, 2025

Patient Awareness of Pharmacogenomic Testing Remains Low, ACS CAN Survey Reports

Less than half of responding patients with cancer were previously familiar with pharmacogenomic testing and its possible benefits, according to the results of a survey conducted by the American Cancer...

The ASCO Post

August 22, 2025

PSMA PET/CT and Salvage Radiotherapy in Recurrent Prostate Cancer

Use of prostate-specific membrane antigen (PSMA) PET/CT before undergoing salvage radiotherapy was associated with an improved overall survival and biochemical recurrence–free survival compared those ...

The ASCO Post

August 22, 2025

Web Tool Seeks to Reduce State Lung Cancer Mortality Rates

Experts from the National Lung Cancer Roundtable have created a customizable, web-based platform that allows groups and local leaders to develop state-based action plans for reducing lung cancer morta...

The ASCO Post

August 22, 2025

Genomics-Guided Tool to Inform Treatment of Advanced Kidney Cancers

Results from a recent study may help to explain why a rare and hyper-aggressive subtype of kidney cancer is susceptible to immunotherapy—information that helped researchers create a first-of-its-kind ...

The ASCO Post

August 22, 2025

Genetic Testing May Reduce Chemotherapy Side Effects for Patients With GI Cancers

Testing for variants in two genes before starting chemotherapy may significantly improve patient safety by providing physicians with information to help tailor doses, according to new research.

The ASCO Post

August 22, 2025

Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers

In an Australian–New Zealand phase II trial (MoST-CIRCUIT) reported in JAMA Oncology, Gao et al found that the combination of nivolumab and ipilimumab showed “encouraging activity” in patients with ad...

The ASCO Post